http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1085406-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-90
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
filingDate 1976-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1980-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9822c817a114eda1809d6d890b8cca3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22069bdddc302d986537878e4b418e43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d83d3ce515ff87003760620a7e2599ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83d7ec37d6e59b5c80339813ad7c0657
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_318e34accb6535b6e6dc04633e9820cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cfedeb78d4ff96319c6dba9b26319f9
publicationDate 1980-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-1085406-A
titleOfInvention Isobutyl methyl-1,4-dihydro-2,6-dimethyl-4-(2- nitrophenyl)-3,5-pyridindicarboxylate
abstract A 1,4-dihydropyridine-3,5-dicarboxylic acid di-ester derivative, several processes for its preparation and its use as a coronary therapeutic agent. Abstract of the disclosure The present invention relates to the new isobutyl methyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridine-dicarboxylate several processes for its preparation and its use as a coronary therapeutic agent. The compound according to the invention is chiral and can exist in stereoisomeric forms which have a mirror image relationship to each other (enantiomers, antipodes). These can, in turn, again occur in different confor-mations. Both the racemic form and the antipodes are included within the present invention.
priorityDate 1975-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7361
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4499
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474346
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6560
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8038
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13673470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID522677
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6452036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414862564
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104822
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559194
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521682
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11876195
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158119858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523396
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426111084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425739715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429310932
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID96
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408834051
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8209
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425535208
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512847
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12218865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523358
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426185304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539432
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153827112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420001195
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448865858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426654320

Total number of triples: 69.